Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
AAO, accessed, advertising, afflicted, age, Air, Akina, amenable, annum, art, Atomic, bankruptcy, barred, begun, biodegradable, breadth, broadly, burn, certainty, cGCP, civil, Clean, clear, clearance, closure, comprehensive, compromise, concept, Conservation, contractual, convenience, correspondingly, critical, customary, cutoff, damage, damaging, decade, decision, denial, deter, disseminated, distressed, documentary, duration, ease, easy, emerged, encompassed, Enivsia, Europe, European, eventually, experienced, experimental, exploit, exploratory, export, expose, exposed, factual, fall, fewer, field, Fifty, forfeited, grantee, GreyBug, healthcare, hydrophilic, hydrophobic, imaging, incidence, IND, injunction, inspect, inspection, invalid, invalidate, invalidated, invalidity, inventorship, irreversibly, Kala, label, labeling, Landscape, legislation, lost, malfeasance, mandatory, matrix, maximum, meaningfully, Medicaid, Medicare, misappropriation, movement, MPP, multicenter, naive, nanoparticle, necessarily, negotiate, negotiation, nonassessable, nonrenewal, Obama, Occupational, opportunity, opposition, pace, packaging, particle, passed, passive, patentee, path, percentage, pharmacodynamic, pharmacokinetic, pharmacology, pivotal, plant, polymer, post, precluded, predictor, preliminary, premarket, presence, prespecified, PRINT, privacy, profitability, promotion, proof, proximity, publicly, radioactive, randomly, reaction, Ready, recoup, Recovery, reexamination, relieve, rented, repeat, reputation, Restoration, revocation, revoked, risen, satisfactorily, satisfactory, satisfy, scale, secret, sector, semiannual, shorten, shortened, Similarly, SPA, speculative, statutory, stolen, storage, store, stored, substance, suffer, suffered, supplant, supply, susceptible, suspended, takeover, temporary, text, Therapeutix, therecan, thereunder, threatened, timeframe, timeline, toxicology, transfer, tree, turn, Tyrogenex, unclear, undergo, undermine, undermined, underway, underwritten, Union, unobservable, unpatented, unreliable, unreported, unsolicited, Uruguay, versatility, viable, violation, vulnerable, waiver, warning, Water, Wehave
Removed:
accredited, acquirer, acted, Adam, adequacy, advice, advisor, Advisory, affiliated, afforded, amino, Anderson, antimalarial, antiviral, appetite, applied, assisting, attestation, auditing, auditor, Austin, banker, banking, behalf, belted, Benchmark, BFK, biodistribution, biographical, biological, body, Bombay, bond, Bradshaw, broadband, brought, cachexia, Canada, cancer, caption, center, Centre, CFO, chairman, characterized, chemical, chemistry, chemotherapy, clouding, coagulation, College, Columbia, compliant, composed, conclude, conference, confirm, consecutive, consent, consult, consummated, consumption, convert, corneal, Cornell, corrected, counsel, covalently, covenant, decreased, defendant, Defense, delivering, Department, description, desired, diadenosine, diligence, dinucleotide, disagreement, discharge, disclaimer, discretion, dismissal, dismissed, disposing, division, dose, dosing, Dutch, earned, effort, enterprise, entry, escalation, examined, exceeded, exhibited, expanded, extensively, fact, female, finance, Flom, Foerster, forum, forward, foundation, founded, front, funded, Genaera, GlaxoSmithKline, graduated, Greenstein, hematology, Hirschman, histopathological, histopathology, Hospital, IDT, IIa, immunomodulator, India, instillation, interval, intranasal, intraocular, Ira, irritation, iSonep, joining, lectured, led, letter, leveraged, Liquidating, listing, LPath, macroscopic, Macula, male, maritime, Meagher, meant, medicinal, methodology, microbiology, microscopic, microscopically, Minnesota, monitor, Morrison, multi, muscle, Mystic, necropsy, nominating, nomination, noncompetition, NYSE, Ontario, ophthalmoscopic, optical, originally, Orin, OSHA, Ottawa, PAREXEL, person, Pfizer, Pharmacy, Philadelphia, phosphodiester, plasma, PLLC, postdoctoral, posterior, predetermined, professional, progressed, proved, provision, pursuing, radiation, Randall, receptionist, recommend, recommendation, recommended, region, reliable, remediate, remuneration, renamed, represent, representation, repurchase, residual, response, restructuring, rheumatoid, Rose, Rule, Sandoz, School, Science, secondary, secretary, secured, senior, serine, serve, served, Shalom, shell, Simon, single, singular, Skadden, Slate, Smith, Southwest, sponsored, stabilization, stable, sterilized, structuring, subsequently, supervision, supplemented, swelling, systemic, temperature, terminally, tissue, Tolerance, Toronto, Touro, toxicokinetic, Treasury, Trough, Trust, unanimously, underlying, undesirable, unique, University, Unregistered, unwilling, urine, Utah, Viral, warrant, weight, Wesray, William, worked
Filing tables
Filing exhibits
- 10-K Annual report
- 10.2 Consulting Agreement and Release
- 10.2 Restricted Stock Agreement
- 10.2 Lock-up Agreement
- 10.2 Proprietary Information and Inventions Agreement
- 10.3 Proprietary Information and Inventions Agreement
- 10.8 Amendment to 2014 Stock Incentive Plan
- 14 Code of Ethics
- 21 List of Subsidiaries of Ohr Pharmaceutical. Inc.
- 23 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of Chief Executive Officer
- 31.2 Chief Financial Officer and Principal Accounting Officer
- 32.1 Certification of Chief Executive Officer
- 32.2 Chief Financial Officer and Principal Accounting Officer
- Download Excel data file
- View Excel data file
Related press release
NBSE similar filings
Filing view
External links
Exhibit 32.1
Certification of Chief Executive Officer
Pursuant to 18 U.S.C Section 1350,
As Adopted Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002
Not Filed Pursuant to the Securities Exchange Act of 1934
In connection with the Annual Report of Ohr Pharmaceutical, Inc. (the“Company”) on Form 10-K for the fiscal year ended September 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the“Report”), I, Jason Slakter, Chief Executive Officer, of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: December 14, 2015
/s/ Jason Slakter | ||
Name: | Jason Slakter | |
Title: | Chief Executive Officer |